» Articles » PMID: 21906291

Factors Associated with Default from Treatment Among Tuberculosis Patients in Nairobi Province, Kenya: a Case Control Study

Overview
Publisher Biomed Central
Specialty Public Health
Date 2011 Sep 13
PMID 21906291
Citations 121
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Successful treatment of tuberculosis (TB) involves taking anti-tuberculosis drugs for at least six months. Poor adherence to treatment means patients remain infectious for longer, are more likely to relapse or succumb to tuberculosis and could result in treatment failure as well as foster emergence of drug resistant tuberculosis. Kenya is among countries with high tuberculosis burden globally. The purpose of this study was to determine the duration tuberculosis patients stay in treatment before defaulting and factors associated with default in Nairobi.

Methods: A Case-Control study; Cases were those who defaulted from treatment and Controls those who completed treatment course between January 2006 and March 2008. All (945) defaulters and 1033 randomly selected controls from among 5659 patients who completed treatment course in 30 high volume sites were enrolled. Secondary data was collected using a facility questionnaire. From among the enrolled, 120 cases and 154 controls were randomly selected and interviewed to obtain primary data not routinely collected. Data was analyzed using SPSS and Epi Info statistical software. Univariate and multivariate logistic regression analysis to determine association and Kaplan-Meier method to determine probability of staying in treatment over time were applied.

Results: Of 945 defaulters, 22.7% (215) and 20.4% (193) abandoned treatment within first and second months (intensive phase) of treatment respectively. Among 120 defaulters interviewed, 16.7% (20) attributed their default to ignorance, 12.5% (15) to traveling away from treatment site, 11.7% (14) to feeling better and 10.8% (13) to side-effects. On multivariate analysis, inadequate knowledge on tuberculosis (OR 8.67; 95% CI 1.47-51.3), herbal medication use (OR 5.7; 95% CI 1.37-23.7), low income (OR 5.57, CI 1.07-30.0), alcohol abuse (OR 4.97; 95% CI 1.56-15.9), previous default (OR 2.33; 95% CI 1.16-4.68), co-infection with Human immune-deficient Virus (HIV) (OR 1.56; 95% CI 1.25-1.94) and male gender (OR 1.43; 95% CI 1.15-1.78) were independently associated with default.

Conclusion: The rate of defaulting was highest during initial two months, the intensive phase of treatment. Multiple factors were attributed by defaulting patients as cause for abandoning treatment whereas several were independently associated with default. Enhanced patient pre-treatment counseling and education about TB is recommended.

Citing Articles

Integrating narrative and bibliometric approaches to examine factors and impacts of tuberculosis treatment non-compliance.

Santosa A, Juniarti N, Pahria T, Susanti R Multidiscip Respir Med. 2025; 20.

PMID: 40017294 PMC: 11875689. DOI: 10.5826/mrm.2025.1016.


Factors influencing treatment success in drug-susceptible tuberculosis patients in Ghana: A prospective cohort study.

Djochie R, Anto B, Opare-Addo M, Boakye-Yiadom J PLOS Glob Public Health. 2025; 5(2):e0004146.

PMID: 39982958 PMC: 11844882. DOI: 10.1371/journal.pgph.0004146.


An Evaluation of Medication Adherence in New Tuberculosis Cases in Ankara: A Prospective Cohort Study.

Ozaltun S, Akin L Healthcare (Basel). 2024; 12(23).

PMID: 39684975 PMC: 11641275. DOI: 10.3390/healthcare12232353.


Social and health factors associated with unfavourable treatment outcomes in children and adolescents with drug-sensitive tuberculosis in Brazil: a national retrospective cohort study.

Santos V, de Holanda J, Gois-Neto R, Maciel E, Dockhorn Costa Johansen F, Silva-Junior J Lancet Reg Health Am. 2024; 40:100938.

PMID: 39628672 PMC: 11613200. DOI: 10.1016/j.lana.2024.100938.


[Tuberculosis in childhood and adolescence: prevalence and factors associated with treatment abandonment].

Soledade M, Yamauti S, Aguiar A, Sucupira C, Crozatti M Cad Saude Publica. 2024; 40(9):e00158323.

PMID: 39292064 PMC: 11405015. DOI: 10.1590/0102-311XPT158323.


References
1.
Daniel O, Oladapo O, Alausa O . Default from tuberculosis treatment programme in Sagamu, Nigeria. Niger J Med. 2006; 15(1):63-7. DOI: 10.4314/njm.v15i1.37119. View

2.
Jakubowiak W, Bogorodskaya E, Borisov S, Borisov E, Danilova I, Danilova D . Risk factors associated with default among new pulmonary TB patients and social support in six Russian regions. Int J Tuberc Lung Dis. 2007; 11(1):46-53. View

3.
. Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30.... Am Rev Respir Dis. 1991; 143(4 Pt 1):700-6. DOI: 10.1164/ajrccm/143.4_Pt_1.700. View

4.
Munro S, Lewin S, Smith H, Engel M, Fretheim A, Volmink J . Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med. 2007; 4(7):e238. PMC: 1925126. DOI: 10.1371/journal.pmed.0040238. View

5.
Oliveira V, da Cunha A, Alves R . Tuberculosis treatment default among Brazilian children. Int J Tuberc Lung Dis. 2006; 10(8):864-9. View